Patent · US Active

Inhibition of Hsp27 phosphorylation for the treatment of blistering disorders

US8008093B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

The University of North Carolina at Chapel Hill · US

Inventors

David Scott RUBENSTEIN · Chapel Hill, US
Paula Berkowitz · Chapel Hill, US
Peiqi Hu · Chapel Hill, US
Luis Diaz · Ellicott City, US

Key dates

Filing date	Dec 2, 2005
Grant date	Aug 30, 2011
Priority date	—
Expiry date	Jul 20, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P17/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating a blistering disorder, which includes administering to a target tissue in a subject in need thereof an effective amount of a composition that inhibits activation of the HSP27 phosphorylation pathway.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.